D 2004

Molecular Cytogenetic Characterization of Glioblastoma Using the Technique of in situ Fluorescence Hybridization, Comparative Genome Hybridization and Spectral Karyotyping.

CEJPEK, Pavel, Petr KUGLÍK, Renata VESELSKÁ, Martina PEŠÁKOVÁ, Petr KRUPA et. al.

Basic information

Original name

Molecular Cytogenetic Characterization of Glioblastoma Using the Technique of in situ Fluorescence Hybridization, Comparative Genome Hybridization and Spectral Karyotyping.

Name in Czech

Molekulárně cytogenetická charakteristika multiformního glioblastomu pomocí techniky fluorescenční hybridizace in situ, komparativní genomové hybridizace a spektrálního karyotypování

Authors

CEJPEK, Pavel (203 Czech Republic, guarantor), Petr KUGLÍK (203 Czech Republic), Renata VESELSKÁ (203 Czech Republic), Martina PEŠÁKOVÁ (203 Czech Republic), Petr KRUPA (203 Czech Republic), Jiřina RELICHOVÁ (203 Czech Republic), Václav VYBÍHAL (203 Czech Republic), Petr MLEJNEK (203 Czech Republic), Eva LŽIČAŘOVÁ (203 Czech Republic) and J. HORKÝ (203 Czech Republic)

Edition

Brno, 9th European Workshop on Cytogenetics and Molecular Genetics of Human Solid Tumours - Book of abstracts, p. 54-54, 2004

Publisher

Kongresové centrum, Brno

Other information

Language

English

Type of outcome

Stať ve sborníku

Field of Study

10600 1.6 Biological sciences

Country of publisher

Czech Republic

Confidentiality degree

není předmětem státního či obchodního tajemství

RIV identification code

RIV/00216224:14310/04:00011045

Organization unit

Faculty of Science

ISBN

80-86607-12-7

Keywords in English

Glioblastoma multiforme; FISH; CGH; SKY
Změněno: 4/12/2006 15:37, doc. RNDr. Petr Kuglík, CSc.

Abstract

V originále

The glioblastoma of brain ranks with the most malign tumours of the central nervous system. The aims of this study was to perform molecular cytogenetic characterization of genetic changes in 18 patients with GBM.

In Czech

Pomocí molekulárně cytogenetických metod byly studovány specifické chromozomové abnormality u 18 pacientů s multiformním glioblastomem.

Links

OC B19.001, research and development project
Name: Genová diagnostika a terapie multiformního glioblastomu (Acronym: COST)
Investor: Ministry of Education, Youth and Sports of the CR, Gene Diagnostics and Therapy of Multiform Glioblastoma